<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Computational chemistry / Pharmacology / Drug discovery / Cheminformatics / Quantitative structure–activity relationship / Drug design / Matrix metalloproteinase / Structure–activity relationship / Chemistry / Medicinal chemistry / Science
Pharmaceutical sciences
Computational chemistry
Pharmacology
Drug discovery
Cheminformatics
Quantitative structure–activity relationship
Drug design
Matrix metalloproteinase
Structure–activity relationship
Chemistry
Medicinal chemistry
Science

Openness as infrastructure

Add to Reading List

Source URL: www.jcheminf.com

Download Document from Source Website

File Size: 1,74 MB

Share Document on Facebook

Similar Documents

Medicinal chemistry / Cheminformatics / Drug discovery / Computational chemistry / Quantitative structureactivity relationship / Clinical research / Structureactivity relationship / Chemical substance / Matched molecular pair analysis

Identifying Structure-Activity Cliffs in a Salmonella QSAR Model for Predicting the Potential Mutagenicity of Genotoxic Drug Impurities and Other Organic Molecules P46 Kevin P. Cross1, R. Daniel Benz2, Lidiya Stavitskay

DocID: 1ptdl - View Document

Structure-Activity Relationship Clusters (and the Difference between 2-D and 3-D Similarity) Volker D. Hähnke, Lianyi Han, Sunghwan Kim, Evan E. Bolton, Stephen H. Bryant National Center for Biotechnology Information Na

DocID: 1nWaq - View Document

Chemistry / Learning / Cheminformatics / Statistics / Drug discovery / Computational chemistry / Statistical classification / Mathematical chemistry / Kernel method / Graph kernel / Support vector machine / Organic chemistry

1 Kernel methods for SAR Modeling Biological Activities of Chemical Compounds: Kernel Methods for Structure Activity Relationship

DocID: 1lOjV - View Document

Toxicology / Alternatives to animal testing / Endocrine system / Chemistry / Quantitative structure–activity relationship / Science / Medicine / Endocrinology / Pharmacology / Endocrine disruptor

Mapping the Human Toxome by Systems Toxicology Using ED as Proof of Concept Thomas Hartung Doerenkamp-Zbinden Professor and Chair for Evidence-based Toxicology, EHS Director, Center for Alternatives to Animal Testing (CA

DocID: 1fRGs - View Document

Pharmacology / Cheminformatics / Drug discovery / Medicinal chemistry / Computational chemistry / Quantitative structure–activity relationship / Molecular descriptor / Drug design / Pharmaceutical sciences / Science / Chemistry

Data Mining in Bioinformatics Day 8: Graph Mining for Chemoinformatics and Drug Discovery Chloé-Agathe Azencott Machine Learning & Computational Biology Research Group MPIs Tübingen

DocID: 1fB0S - View Document